Archive for January, 2008

January 31, 2008: 12:00 am: adminCancéropôle Lyon Rhône-Alpes

Terry D. Etherton

Genetically engineered (GE) animals provide innovative technologies that can transform public health through biomedical, food and environmental applications, according to a scientific report released by the Biotechnology Industry Organization (BIO).

The report, Genetically Engineered Animals and Public Health – Compelling Benefits for Health Care, Nutrition, the Environment and Animal Welfare, discusses how GE animals will enhance human health, food production, environmental protection, animal health and cutting-edge industrial applications. The report was authored by Scott Gottlieb, MD, of the American Enterprise Institute, and Matthew B. Wheeler, PhD, of the Institute for Genomic Biology, University of Illinois at Urbana-Champaign. Dr. Gottlieb and Dr. Wheeler are experts in the field of genetic engineering of animals.

Genetic engineering is the deliberate modification of the animal’s genome using the scientific tools of modern biotechnology. By incorporating genes from other organisms in a process called transgenesis, GE animals are being developed to address five broad goals:

  • Advance human health: GE animals will improve human health by producing novel replacement proteins, drugs, vaccines and tissues for the treatment and prevention of human disease.
  • Enhance food production and quality: Animals that are genetically engineered will have improved food production capabilities, enabling them to help meet the global demand for more efficient, higher quality and lower-cost sources of food.
  • Mitigate environmental impact: GE animals will contribute to improving the environment and human health by consuming fewer resources and producing less waste.
  • Optimize animal welfare. Genetic engineering offers tremendous benefits to the animals by enhancing the health, well-being and welfare of the animal itself.
  • Improve industrial products: Genetic engineering can produce high-value industrial products, such as spider silk, for both medical and defense applications.
  • “There are now dozens of products under development derived from genetically engineered animals that hold promise of benefit to human health,” says Dr. Gottlieb. “But the practical benefits of this technology have not yet reached American patients and consumers primarily because of regulatory and political obstacles rather than the limits of science.”

    The authors make a strong case for creating a regulatory pathway for commercialization of these beneficial biotechnologies. The Bio Report illustrates how the production of GE animals promises benefits for both biomedicine and agriculture. But Gottlieb and Wheeler agree that the science requires regulations that bridge the divide between food and biomedical products.

    I have written extensively about the importance of biotechnology in the Terry Etherton Blog on Biotechnology. The BIO Report, Genetically Engineered Animals and Public Health – Compelling Benefits for Health Care, Nutrition, the Environment and Animal Welfare, reinforces the need for and value of biotechnology in society. The numerous benefits of of GE animals only can be realized when policy obstacles are resolved that are limiting investment in this research and holding back product development.

    Permalink

    Comments are closed.

    : 12:00 am: adminCancéropôle Lyon Rhône-Alpes

    Permalink

    Leave a Comment

    You must be logged in to post a comment.

    : 12:00 am: adminCancéropôle Lyon Rhône-Alpes

    Terry D. Etherton

    Genetically engineered (GE) animals provide innovative technologies that can transform public health through biomedical, food and environmental applications, according to a scientific report released by the Biotechnology Industry Organization (BIO).

    The report, Genetically Engineered Animals and Public Health – Compelling Benefits for Health Care, Nutrition, the Environment and Animal Welfare, discusses how GE animals will enhance human health, food production, environmental protection, animal health and cutting-edge industrial applications. The report was authored by Scott Gottlieb, MD, of the American Enterprise Institute, and Matthew B. Wheeler, PhD, of the Institute for Genomic Biology, University of Illinois at Urbana-Champaign. Dr. Gottlieb and Dr. Wheeler are experts in the field of genetic engineering of animals.

    Genetic engineering is the deliberate modification of the animal’s genome using the scientific tools of modern biotechnology. By incorporating genes from other organisms in a process called transgenesis, GE animals are being developed to address five broad goals:

  • Advance human health: GE animals will improve human health by producing novel replacement proteins, drugs, vaccines and tissues for the treatment and prevention of human disease.
  • Enhance food production and quality: Animals that are genetically engineered will have improved food production capabilities, enabling them to help meet the global demand for more efficient, higher quality and lower-cost sources of food.
  • Mitigate environmental impact: GE animals will contribute to improving the environment and human health by consuming fewer resources and producing less waste.
  • Optimize animal welfare. Genetic engineering offers tremendous benefits to the animals by enhancing the health, well-being and welfare of the animal itself.
  • Improve industrial products: Genetic engineering can produce high-value industrial products, such as spider silk, for both medical and defense applications.
  • “There are now dozens of products under development derived from genetically engineered animals that hold promise of benefit to human health,” says Dr. Gottlieb. “But the practical benefits of this technology have not yet reached American patients and consumers primarily because of regulatory and political obstacles rather than the limits of science.”

    The authors make a strong case for creating a regulatory pathway for commercialization of these beneficial biotechnologies. The Bio Report illustrates how the production of GE animals promises benefits for both biomedicine and agriculture. But Gottlieb and Wheeler agree that the science requires regulations that bridge the divide between food and biomedical products.

    I have written extensively about the importance of biotechnology in the Terry Etherton Blog on Biotechnology. The BIO Report, Genetically Engineered Animals and Public Health – Compelling Benefits for Health Care, Nutrition, the Environment and Animal Welfare, reinforces the need for and value of biotechnology in society. The numerous benefits of of GE animals only can be realized when policy obstacles are resolved that are limiting investment in this research and holding back product development.

    Permalink

    Comments are closed.

    : 12:00 am: adminCancéropôle Lyon Rhône-Alpes

    Permalink

    Leave a Comment

    You must be logged in to post a comment.

    : 12:00 am: adminCancéropôle Lyon Rhône-Alpes

    Terry D. Etherton

    Genetically engineered (GE) animals provide innovative technologies that can transform public health through biomedical, food and environmental applications, according to a scientific report released by the Biotechnology Industry Organization (BIO).

    The report, Genetically Engineered Animals and Public Health – Compelling Benefits for Health Care, Nutrition, the Environment and Animal Welfare, discusses how GE animals will enhance human health, food production, environmental protection, animal health and cutting-edge industrial applications. The report was authored by Scott Gottlieb, MD, of the American Enterprise Institute, and Matthew B. Wheeler, PhD, of the Institute for Genomic Biology, University of Illinois at Urbana-Champaign. Dr. Gottlieb and Dr. Wheeler are experts in the field of genetic engineering of animals.

    Genetic engineering is the deliberate modification of the animal’s genome using the scientific tools of modern biotechnology. By incorporating genes from other organisms in a process called transgenesis, GE animals are being developed to address five broad goals:

  • Advance human health: GE animals will improve human health by producing novel replacement proteins, drugs, vaccines and tissues for the treatment and prevention of human disease.
  • Enhance food production and quality: Animals that are genetically engineered will have improved food production capabilities, enabling them to help meet the global demand for more efficient, higher quality and lower-cost sources of food.
  • Mitigate environmental impact: GE animals will contribute to improving the environment and human health by consuming fewer resources and producing less waste.
  • Optimize animal welfare. Genetic engineering offers tremendous benefits to the animals by enhancing the health, well-being and welfare of the animal itself.
  • Improve industrial products: Genetic engineering can produce high-value industrial products, such as spider silk, for both medical and defense applications.
  • “There are now dozens of products under development derived from genetically engineered animals that hold promise of benefit to human health,” says Dr. Gottlieb. “But the practical benefits of this technology have not yet reached American patients and consumers primarily because of regulatory and political obstacles rather than the limits of science.”

    The authors make a strong case for creating a regulatory pathway for commercialization of these beneficial biotechnologies. The Bio Report illustrates how the production of GE animals promises benefits for both biomedicine and agriculture. But Gottlieb and Wheeler agree that the science requires regulations that bridge the divide between food and biomedical products.

    I have written extensively about the importance of biotechnology in the Terry Etherton Blog on Biotechnology. The BIO Report, Genetically Engineered Animals and Public Health – Compelling Benefits for Health Care, Nutrition, the Environment and Animal Welfare, reinforces the need for and value of biotechnology in society. The numerous benefits of of GE animals only can be realized when policy obstacles are resolved that are limiting investment in this research and holding back product development.

    Permalink

    Comments are closed.

    : 12:00 am: adminCancéropôle Lyon Rhône-Alpes

    Permalink

    Leave a Comment

    You must be logged in to post a comment.

    January 29, 2008: 12:00 am: adminCancéropôle Lyon Rhône-Alpes

    Socio-Economic Benefits Becoming Evident Among Resource-Poor Farmers

    MANILA, PHILIPPINES (Feb. 13, 2008) – After a dozen years of commercialization, biotech crops are still gaining ground with another year of double-digit growth, and new countries joining the list of supporters, according to a report released today by the International Service for the Acquisition of Agri-biotech Applications (ISAAA). In 2007, biotech crop area grew 12 percent or 12.3 million hectares to reach 114.3 million hectares, the second highest area increase in the past five years.In addition to planting more biotech hectares, farmers are quickly adopting varieties with more than one biotech trait. These “trait hectares” grew at a swift 22 percent, or 26 million hectares, to reach 143.7 million hectares – more than double the area increase of 12.3 million hectares. New crops were also added to the list as China reported 250,000 biotech poplar trees planted. The insect-resistant trees can contribute to reforestation efforts.

    Further, 2 million more farmers planted biotech crops last year to total 12 million farmers globally enjoying the advantages from the improved technology. Notably, 9 out of 10, or 11 million of the benefiting farmers, were resource-poor farmers, exceeding the 10-million milestone for the first time. In fact, the number of developing countries (12) planting biotech crops surpassed the number of industrialized countries (11), and the growth rate in the developing world was three times that of industrialized nations (21 percent compared to 6 percent.)

    “With increasing food prices globally, the benefits of biotech crops have never been more important,” said Clive James, chairman and founder of ISAAA and the report’s author. “Already those farmers who began adopting biotech crops a few years ago are beginning to see socio-economic advantages compared to their peers who haven’t adopted the crops. If we are to achieve the Millennium Development Goals (MDGs) of cutting hunger and poverty in half by 2015, biotech crops must play an even bigger role in the next decade.”

    According to the report, biotech crops have delivered unprecedented benefits that contribute toward the MDGs, particularly in countries like China, India and South Africa. The potential in the second decade of biotech crop commercialization (2006-2015) is enormous.

    Studies in India and China show Bt cotton has increased yields by up to 50 percent and 10 percent, respectively, and reduced insecticide use in both countries up to 50 percent or more. In India, growers increased income up to $250 or more per hectare, increasing farmer income nationally from $840 million to $1.7 billion last year. Chinese farmers saw similar gains with incomes growing an average of $220 per hectare, or more than $800 million nationally. Importantly, these studies showed strong farmer confidence in the crops with 9 of 10 Indian farmers replanting biotech cotton year on year, and 100 percent of Chinese farmers choosing to continue utilizing the technology.

    While these types of economic benefits are well substantiated, the socio-economic benefits associated with biotech crops are starting to emerge. A study of 9,300 Bt cotton and non-Bt cotton-growing households in India indicated that women and children in Bt cotton households have slightly more access to social benefits than non-Bt cotton growers. These include slight increases in pre-natal visits, assistance with at-home births, higher school enrollment for children and a higher proportion of children vaccinated.

    Rosalie Ellasus, a widowed mother of 3 children, found similar benefits, chosing farming as a way to support her family. “With the extra income generated from biotech maize, investing in farming made sense and allowed me to earn more than the medical technology field I was trained in,” she said. “The biotech maize gave me peace of mind and meant less time monitoring for pests. With stack corn, I also incur savings on cultivation and weeding costs. With the added income, I have been able to send all my children to college.”

    “It’s these types of benefits that will make crop biotechnology a vital tool in achieving the U.N. Millennium Development Goals of cutting hunger and poverty in half and ensuring a more sustainable agriculture in the future,” James said. “To reach these goals, a continued broadening and deepening of biotech crop use is crucial to meeting food, feed, fiber and fuel needs in the future.”

    In 2007, the United States, Argentina, Brazil, Canada, India and China continued to be the principal adopters of biotech crops globally. While the United States continues to be the largest user of the technology, its biotech crop area represents a declining share of the global area due to a broadening adoption. [Editor’s note: see ISAAA Country Fact Sheet for additional detail on specific countries.]

    “With a dozen years of accumulated knowledge and significant economic, environmental and socio-economic benefits, biotech crops are poised for even greater growth in coming years, particularly in developing countries that have the greatest need for this technology,” James said.

    According to the report, Burkina Faso, Egypt and possibly Vietnam are the next mostly likely countries to approve biotech crops. Australia is field-testing drought-tolerant wheat and two states recently lifted a four-year ban on biotech canola. Finally, countries like India recognize the importance of using biotechnology to make the country self-sufficient in food grains, including rice, wheat and oil seed production with the first biotech food crop, biotech eggplant, expecting approval in the near-term.

    “I predict the number of biotech countries, crops, traits, area and farmers will all grow substantially in the second decade of adoption,” James said. “More developing countries are likely to approve the technology as it’s now possible to design regulatory systems that are rigorous without being onerous given their limited resources. The current delay in timely approvals of biotech crops like golden rice with benefits for millions is a moral dilemma where the demands of regulatory systems have often become the end and not the means.”

    The report is entirely funded by the Rockefeller Foundation, a U.S.-based philanthropic organization associated with the Green Revolution; Ibercaja, one of the largest Spanish banks headquartered in the maize growing region of Spain; and the Bussolera-Branca Foundation from Italy, which supports the open-sharing of knowledge on biotech crops to aid decision-making by global society.

    Permalink

    Comments are closed.

    : 12:00 am: adminCancéropôle Lyon Rhône-Alpes

    Socio-Economic Benefits Becoming Evident Among Resource-Poor Farmers

    MANILA, PHILIPPINES (Feb. 13, 2008) – After a dozen years of commercialization, biotech crops are still gaining ground with another year of double-digit growth, and new countries joining the list of supporters, according to a report released today by the International Service for the Acquisition of Agri-biotech Applications (ISAAA). In 2007, biotech crop area grew 12 percent or 12.3 million hectares to reach 114.3 million hectares, the second highest area increase in the past five years.In addition to planting more biotech hectares, farmers are quickly adopting varieties with more than one biotech trait. These “trait hectares” grew at a swift 22 percent, or 26 million hectares, to reach 143.7 million hectares – more than double the area increase of 12.3 million hectares. New crops were also added to the list as China reported 250,000 biotech poplar trees planted. The insect-resistant trees can contribute to reforestation efforts.

    Further, 2 million more farmers planted biotech crops last year to total 12 million farmers globally enjoying the advantages from the improved technology. Notably, 9 out of 10, or 11 million of the benefiting farmers, were resource-poor farmers, exceeding the 10-million milestone for the first time. In fact, the number of developing countries (12) planting biotech crops surpassed the number of industrialized countries (11), and the growth rate in the developing world was three times that of industrialized nations (21 percent compared to 6 percent.)

    “With increasing food prices globally, the benefits of biotech crops have never been more important,” said Clive James, chairman and founder of ISAAA and the report’s author. “Already those farmers who began adopting biotech crops a few years ago are beginning to see socio-economic advantages compared to their peers who haven’t adopted the crops. If we are to achieve the Millennium Development Goals (MDGs) of cutting hunger and poverty in half by 2015, biotech crops must play an even bigger role in the next decade.”

    According to the report, biotech crops have delivered unprecedented benefits that contribute toward the MDGs, particularly in countries like China, India and South Africa. The potential in the second decade of biotech crop commercialization (2006-2015) is enormous.

    Studies in India and China show Bt cotton has increased yields by up to 50 percent and 10 percent, respectively, and reduced insecticide use in both countries up to 50 percent or more. In India, growers increased income up to $250 or more per hectare, increasing farmer income nationally from $840 million to $1.7 billion last year. Chinese farmers saw similar gains with incomes growing an average of $220 per hectare, or more than $800 million nationally. Importantly, these studies showed strong farmer confidence in the crops with 9 of 10 Indian farmers replanting biotech cotton year on year, and 100 percent of Chinese farmers choosing to continue utilizing the technology.

    While these types of economic benefits are well substantiated, the socio-economic benefits associated with biotech crops are starting to emerge. A study of 9,300 Bt cotton and non-Bt cotton-growing households in India indicated that women and children in Bt cotton households have slightly more access to social benefits than non-Bt cotton growers. These include slight increases in pre-natal visits, assistance with at-home births, higher school enrollment for children and a higher proportion of children vaccinated.

    Rosalie Ellasus, a widowed mother of 3 children, found similar benefits, chosing farming as a way to support her family. “With the extra income generated from biotech maize, investing in farming made sense and allowed me to earn more than the medical technology field I was trained in,” she said. “The biotech maize gave me peace of mind and meant less time monitoring for pests. With stack corn, I also incur savings on cultivation and weeding costs. With the added income, I have been able to send all my children to college.”

    “It’s these types of benefits that will make crop biotechnology a vital tool in achieving the U.N. Millennium Development Goals of cutting hunger and poverty in half and ensuring a more sustainable agriculture in the future,” James said. “To reach these goals, a continued broadening and deepening of biotech crop use is crucial to meeting food, feed, fiber and fuel needs in the future.”

    In 2007, the United States, Argentina, Brazil, Canada, India and China continued to be the principal adopters of biotech crops globally. While the United States continues to be the largest user of the technology, its biotech crop area represents a declining share of the global area due to a broadening adoption. [Editor’s note: see ISAAA Country Fact Sheet for additional detail on specific countries.]

    “With a dozen years of accumulated knowledge and significant economic, environmental and socio-economic benefits, biotech crops are poised for even greater growth in coming years, particularly in developing countries that have the greatest need for this technology,” James said.

    According to the report, Burkina Faso, Egypt and possibly Vietnam are the next mostly likely countries to approve biotech crops. Australia is field-testing drought-tolerant wheat and two states recently lifted a four-year ban on biotech canola. Finally, countries like India recognize the importance of using biotechnology to make the country self-sufficient in food grains, including rice, wheat and oil seed production with the first biotech food crop, biotech eggplant, expecting approval in the near-term.

    “I predict the number of biotech countries, crops, traits, area and farmers will all grow substantially in the second decade of adoption,” James said. “More developing countries are likely to approve the technology as it’s now possible to design regulatory systems that are rigorous without being onerous given their limited resources. The current delay in timely approvals of biotech crops like golden rice with benefits for millions is a moral dilemma where the demands of regulatory systems have often become the end and not the means.”

    The report is entirely funded by the Rockefeller Foundation, a U.S.-based philanthropic organization associated with the Green Revolution; Ibercaja, one of the largest Spanish banks headquartered in the maize growing region of Spain; and the Bussolera-Branca Foundation from Italy, which supports the open-sharing of knowledge on biotech crops to aid decision-making by global society.

    Permalink

    Comments are closed.

    : 12:00 am: adminCancéropôle Lyon Rhône-Alpes

    Socio-Economic Benefits Becoming Evident Among Resource-Poor Farmers

    MANILA, PHILIPPINES (Feb. 13, 2008) – After a dozen years of commercialization, biotech crops are still gaining ground with another year of double-digit growth, and new countries joining the list of supporters, according to a report released today by the International Service for the Acquisition of Agri-biotech Applications (ISAAA). In 2007, biotech crop area grew 12 percent or 12.3 million hectares to reach 114.3 million hectares, the second highest area increase in the past five years.In addition to planting more biotech hectares, farmers are quickly adopting varieties with more than one biotech trait. These “trait hectares” grew at a swift 22 percent, or 26 million hectares, to reach 143.7 million hectares – more than double the area increase of 12.3 million hectares. New crops were also added to the list as China reported 250,000 biotech poplar trees planted. The insect-resistant trees can contribute to reforestation efforts.

    Further, 2 million more farmers planted biotech crops last year to total 12 million farmers globally enjoying the advantages from the improved technology. Notably, 9 out of 10, or 11 million of the benefiting farmers, were resource-poor farmers, exceeding the 10-million milestone for the first time. In fact, the number of developing countries (12) planting biotech crops surpassed the number of industrialized countries (11), and the growth rate in the developing world was three times that of industrialized nations (21 percent compared to 6 percent.)

    “With increasing food prices globally, the benefits of biotech crops have never been more important,” said Clive James, chairman and founder of ISAAA and the report’s author. “Already those farmers who began adopting biotech crops a few years ago are beginning to see socio-economic advantages compared to their peers who haven’t adopted the crops. If we are to achieve the Millennium Development Goals (MDGs) of cutting hunger and poverty in half by 2015, biotech crops must play an even bigger role in the next decade.”

    According to the report, biotech crops have delivered unprecedented benefits that contribute toward the MDGs, particularly in countries like China, India and South Africa. The potential in the second decade of biotech crop commercialization (2006-2015) is enormous.

    Studies in India and China show Bt cotton has increased yields by up to 50 percent and 10 percent, respectively, and reduced insecticide use in both countries up to 50 percent or more. In India, growers increased income up to $250 or more per hectare, increasing farmer income nationally from $840 million to $1.7 billion last year. Chinese farmers saw similar gains with incomes growing an average of $220 per hectare, or more than $800 million nationally. Importantly, these studies showed strong farmer confidence in the crops with 9 of 10 Indian farmers replanting biotech cotton year on year, and 100 percent of Chinese farmers choosing to continue utilizing the technology.

    While these types of economic benefits are well substantiated, the socio-economic benefits associated with biotech crops are starting to emerge. A study of 9,300 Bt cotton and non-Bt cotton-growing households in India indicated that women and children in Bt cotton households have slightly more access to social benefits than non-Bt cotton growers. These include slight increases in pre-natal visits, assistance with at-home births, higher school enrollment for children and a higher proportion of children vaccinated.

    Rosalie Ellasus, a widowed mother of 3 children, found similar benefits, chosing farming as a way to support her family. “With the extra income generated from biotech maize, investing in farming made sense and allowed me to earn more than the medical technology field I was trained in,” she said. “The biotech maize gave me peace of mind and meant less time monitoring for pests. With stack corn, I also incur savings on cultivation and weeding costs. With the added income, I have been able to send all my children to college.”

    “It’s these types of benefits that will make crop biotechnology a vital tool in achieving the U.N. Millennium Development Goals of cutting hunger and poverty in half and ensuring a more sustainable agriculture in the future,” James said. “To reach these goals, a continued broadening and deepening of biotech crop use is crucial to meeting food, feed, fiber and fuel needs in the future.”

    In 2007, the United States, Argentina, Brazil, Canada, India and China continued to be the principal adopters of biotech crops globally. While the United States continues to be the largest user of the technology, its biotech crop area represents a declining share of the global area due to a broadening adoption. [Editor’s note: see ISAAA Country Fact Sheet for additional detail on specific countries.]

    “With a dozen years of accumulated knowledge and significant economic, environmental and socio-economic benefits, biotech crops are poised for even greater growth in coming years, particularly in developing countries that have the greatest need for this technology,” James said.

    According to the report, Burkina Faso, Egypt and possibly Vietnam are the next mostly likely countries to approve biotech crops. Australia is field-testing drought-tolerant wheat and two states recently lifted a four-year ban on biotech canola. Finally, countries like India recognize the importance of using biotechnology to make the country self-sufficient in food grains, including rice, wheat and oil seed production with the first biotech food crop, biotech eggplant, expecting approval in the near-term.

    “I predict the number of biotech countries, crops, traits, area and farmers will all grow substantially in the second decade of adoption,” James said. “More developing countries are likely to approve the technology as it’s now possible to design regulatory systems that are rigorous without being onerous given their limited resources. The current delay in timely approvals of biotech crops like golden rice with benefits for millions is a moral dilemma where the demands of regulatory systems have often become the end and not the means.”

    The report is entirely funded by the Rockefeller Foundation, a U.S.-based philanthropic organization associated with the Green Revolution; Ibercaja, one of the largest Spanish banks headquartered in the maize growing region of Spain; and the Bussolera-Branca Foundation from Italy, which supports the open-sharing of knowledge on biotech crops to aid decision-making by global society.

    Permalink

    Comments are closed.

    January 28, 2008: 12:00 am: adminCancéropôle Lyon Rhône-Alpes

    Steven King
    Irish Examiner.com
    Published July 23, 2008

    IN Gulliver’s Travels, the King of Bobdingnag — the land of the giants — claimed that whoever could make two ears of corn grow where only one grew before was a greater patriot than all the politicians put together.

    It’s sad to note then that nearly 300 years on from the publication of Swift’s satire, the politicians are still standing in the way of an agricultural technology that has the potential to do just that.

    Despite food prices having risen by 50% in two years, the Government appears to have no strategy to reverse things. On the contrary, the direction of policy is all towards supporting the inefficient organic sector. Moreover, it shows no sign of dropping its opposition to new food technologies that offer the prospect, among other things, of higher yields from the same acreage.

    It’s not hard to guess from which quarter in the current coalition the opposition to GM (genetically modified) food principally emanates. Earlier this month, Environment Minister John Gormley mused out loud that Ireland must keep open the option of declaring itself a GM-free zone. This despite the fact that the Food Safety Authority — the expert body — has been generally positive about GM-derived foods.

    In delaying cultivation, the anti-GM lobbies have exacted a heavy price, not least in the Third World. Closer to home, incredibly, the programme for government not only stakes out an anti-GM position but declares itself in favour of biofuels which require land to be given over from food to fuel production.

    Is it any wonder supermarket prices are skyrocketing? The politicians believe, of course, that they are reflecting public concerns. If the entire world was well-fed and food prices were static, stay-as-we-are might be an affordable luxury. But when a large proportion of the world’s population is still undernourished, don’t politicians have a responsibility to show leadership, to support the scientific and agricultural sectors as they explore ways to grow more, better food?

    In a free society, shouldn’t the ultimate decisions lie with consumers who can make up their own minds? As long as the relevant experts are satisfied that GM food is safe — and they are — shouldn’t we be left to decide whether or not to purchase it?

    Isn’t that the correct approach rather than engaging in a spurious, never-ending public debate that will inevitably be hijacked by the tiny number of green fundamentalists? ‘Safe’ is the last word the romantics would use to describe GM. Despite Americans having eaten it for years with no discernible side-effects, these so-called earth-lovers continue to raise claims that eating GM food can cause cancer and liver disease (and heart failure and brain damage and any other unpleasant health complication they can concoct on the basis of some kooky laboratory experiment, one suspects).

    All credit to the self-styled defenders of our environment, though: they have managed to scare the life out of most of us. They are working with the grain: in the current zeitgeist anything processed or industrialised is potentially harmful, while anything that appears to be close to nature is pure and uncorrupted.

    So, rather than embracing GM as opening up the possibility of greater control over the properties of plants, the environmentalists reject it as dangerous interference in nature with all sorts of unknown potential problems.

    Have they forgotten that Mother Nature supplies not only delicious things for us to eat, but also its fair share of toxic fungi, bacteria and viruses?

    There is a clear paradox here. While we in the developed world enjoy prosperity and health as never before, when it comes to GM foods superstition, ignorance and fear appear to be triumphing over human reason. One suspects that if matters had been left to the likes of Greenpeace, we would all still be hunter-gatherers.

    Superstition, of course, is as old as time. When Charles Darwin provided a mechanism for the origin of species by means of natural selection, he violated the ancient notion that species are immutable and created by God in a hierarchy — with humans near the top, just below angels. The superstition about GM is similar: a sense that we are ‘playing God’ by moving genes around.

    The further each generation is from the land and, thereby, a direct knowledge of crop production, the more susceptible to the scaremongering we become.

    Many other innovations that are now commonplace in our lives were met with similar scepticism and opposition when first introduced. Some might be able to recall the horror stories about microwave ovens. Before that, pasteurisation and even technologies such as canning and freezing provoked alarm.

    For all the frightening talk about ‘Frankenstein foods’, though, GM is simply a new tool for plant breeding, a development of what humans have been doing successfully for centuries: breeding wild grasses into wheat and barley, wolves into dogs and so on. In each case, human choice replaced biological chance. The difference is that now we have the ability to isolate the genes which carry specific traits: the randomness has been taken out of the equation. Throughout history there have been those who embraced this kind of change and those who clung to the old ways because they felt at least the risks were known. And since feeding ourselves was the primary occupation of mankind for most of our history, changes in food production have tended to be accepted only very slowly. Modern intensive agriculture has a bad press. The need to increase food production has resulted in the loss of one-fifth of the world’s topsoil and one-third of its forests.

    BUT organic farming is scarcely the answer: it requires even more land to be devoted to agriculture. This is the dirty little secret the disillusioned financiers who give up the rat-race to sell organic jam, the New Age religionists and the middle-class hypochondriacs don’t want you to know. Their response is to turn their fire on new technologies to make agriculture more efficient so more land can be left wild — or to call for us all to eat less and breed less.

    This hostility to GM makes no sense. Already, GM crops have been designed which are insect-resistant or have a herbicide resistance so they need less spraying. Another benefit is that agricultural landdoesn’t require such extensive tilling, which allows more organic matter to accumulate in the soil.

    This is just the beginning. The future holds promise for new GM crop varieties with increased tolerance of drought, heat and cold; with improved disease resistance or nutritional value, or as production systems for pharmaceutical compounds (such as edible vaccines for the developing world) and renewable industrial compounds (such as biodegradable plastics). These ideas might be unfamiliar, but that is no reason to reject them out of hand.

    The discussion of food illustrates a broader need to remind ourselves just how much modern society has achieved in changing the lives of people for the better through the application of science, industry and reason. Perhaps then we will all be better able to see the ideas of the anti-GM brigade for the manure they really are.

    Permalink

    Comments are closed.